Last updated
ImpediMed: Leadership Change
ImpediMed has appointed Dr. Nicole Stout as Chief Clinical Innovation Officer, effective 1 November 2026, a newly created C-suite style role focused on clinical innovation.
Source: GN — ASX:IPD ImpediMed
- Who
- ImpediMed · Australia & New Zealand
- What happened
- ImpediMed has appointed Dr. Nicole Stout as Chief Clinical Innovation Officer, effective 1 November 2026, a newly created C-suite style role focused on clinical innovation.
- When
- 2026-10-26
- Source
- GN — ASX:IPD ImpediMed
- So what
- A change at the top rarely stays at the top.
The leadership read
A change at the top rarely stays at the top. ImpediMed's move reshapes the layer beneath it in the sector as a new leader sets priorities and the team re-forms. Watch the first two or three appointments that follow; they signal direction more reliably than any statement.
Market context: The wider read — a Talent Market Index of 109.3 (Hot), up 7.6 month-on-month — shows Oceania signal flow easing (-6.2pts).
ImpediMed: 2 signals in the last 90 days; 2 tracked across 69 days.
MitchelLake in this thematic
Also at ImpediMed →
More signals across Oceania
Leadership Change · Oceania
Impact Minerals →Impact Minerals, an ASX-listed miner, has appointed a new board member to strengthen its financial expertise.
Leadership Change · Oceania
72andSunny Sydney →72andSunny Sydney has appointed Jessica Thompson as creative director, returning her to a full-time agency role after about 18 months freelancing.
Leadership Change · Oceania
Aware Super →Australian superannuation fund Aware Super is reshaping its investment leadership and promoting staff, with a focus on using AI and data analytics to inform portfolio strategy.
Leadership Change · Oceania
Beforepay Group →Beforepay Group (ASX:B4P) has appointed Kasey Kaplan as CEO and Managing Director.
Leadership Change · Oceania
Macquarie Group →Sydney-based division director Dieu Ndenzako, an industrials specialist with Macquarie since 2008, has agreed terms to leave Macquarie Capital this month, amid reported departures at the unit.
Leadership Change · Oceania
Stakk →Stakk (ASX:SKK) accepted the resignation of non-executive director Andrew Taylor and agreed a share standstill with Taylor's investment vehicle, Kalkine.
Where this lands in our work
- Board Search & Advisory →
Incoming executives reshape governance needs within two quarters.
- Private Equity →
Listed and PE-backed boards renew leadership against a value-creation clock.
- Executive Search: Oceania →
Our Oceania practice runs the searches behind signals like this one.
Intelligence powered by Autonodal ↗